| pubmed-article:17221172 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17221172 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17221172 | lifeskim:mentions | umls-concept:C0085435 | lld:lifeskim |
| pubmed-article:17221172 | lifeskim:mentions | umls-concept:C0005516 | lld:lifeskim |
| pubmed-article:17221172 | lifeskim:mentions | umls-concept:C0150312 | lld:lifeskim |
| pubmed-article:17221172 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:17221172 | pubmed:dateCreated | 2007-5-7 | lld:pubmed |
| pubmed-article:17221172 | pubmed:abstractText | An elevated expression of the alloantigen D8/17 on B lymphocytes has been previously proposed as a susceptibility marker in rheumatic fever. The aim of the study was to investigate the presence of the D8/17 marker on B lymphocytes in poststreptococcal reactive arthritis (PSRA). The study sample included 19 patients (15 boys, 4 girls; mean age 11.7 +/- 5.4 years) who were diagnosed with PSRA (mean age at diagnosis, 9.4 +/- 5.6 years) and 18 healthy controls (10 boys and 8 girls) matched for ethnic background. B-cell D8/17 expression was tested by flow cytometry assay using monoclonal antibodies. Laboratory results showed a higher expression of D8/17 in the patient group (23.1 +/- 10.4%, range 11.6-51.9%) than in the control group (17.1 +/- 8.2%, range 7.1-35.7) in controls; this difference was statistically significant after log transformation of the data (P = 0.035). The high rate of expression of the D8/17 marker in patients with PSRA suggests that RF and PSRA share the same genetic susceptibility. | lld:pubmed |
| pubmed-article:17221172 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17221172 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17221172 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17221172 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17221172 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17221172 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17221172 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:17221172 | pubmed:issn | 0172-8172 | lld:pubmed |
| pubmed-article:17221172 | pubmed:author | pubmed-author:UzielYosefY | lld:pubmed |
| pubmed-article:17221172 | pubmed:author | pubmed-author:PraisDarioD | lld:pubmed |
| pubmed-article:17221172 | pubmed:author | pubmed-author:AmirJacobJ | lld:pubmed |
| pubmed-article:17221172 | pubmed:author | pubmed-author:ZabriskieJohn... | lld:pubmed |
| pubmed-article:17221172 | pubmed:author | pubmed-author:HarelLioraL | lld:pubmed |
| pubmed-article:17221172 | pubmed:author | pubmed-author:MukamelMashaM | lld:pubmed |
| pubmed-article:17221172 | pubmed:author | pubmed-author:ZehariaAbraha... | lld:pubmed |
| pubmed-article:17221172 | pubmed:author | pubmed-author:KodmanYonaY | lld:pubmed |
| pubmed-article:17221172 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17221172 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:17221172 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17221172 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17221172 | pubmed:pagination | 695-8 | lld:pubmed |
| pubmed-article:17221172 | pubmed:meshHeading | pubmed-meshheading:17221172... | lld:pubmed |
| pubmed-article:17221172 | pubmed:meshHeading | pubmed-meshheading:17221172... | lld:pubmed |
| pubmed-article:17221172 | pubmed:meshHeading | pubmed-meshheading:17221172... | lld:pubmed |
| pubmed-article:17221172 | pubmed:meshHeading | pubmed-meshheading:17221172... | lld:pubmed |
| pubmed-article:17221172 | pubmed:meshHeading | pubmed-meshheading:17221172... | lld:pubmed |
| pubmed-article:17221172 | pubmed:meshHeading | pubmed-meshheading:17221172... | lld:pubmed |
| pubmed-article:17221172 | pubmed:meshHeading | pubmed-meshheading:17221172... | lld:pubmed |
| pubmed-article:17221172 | pubmed:meshHeading | pubmed-meshheading:17221172... | lld:pubmed |
| pubmed-article:17221172 | pubmed:meshHeading | pubmed-meshheading:17221172... | lld:pubmed |
| pubmed-article:17221172 | pubmed:meshHeading | pubmed-meshheading:17221172... | lld:pubmed |
| pubmed-article:17221172 | pubmed:meshHeading | pubmed-meshheading:17221172... | lld:pubmed |
| pubmed-article:17221172 | pubmed:meshHeading | pubmed-meshheading:17221172... | lld:pubmed |
| pubmed-article:17221172 | pubmed:meshHeading | pubmed-meshheading:17221172... | lld:pubmed |
| pubmed-article:17221172 | pubmed:meshHeading | pubmed-meshheading:17221172... | lld:pubmed |
| pubmed-article:17221172 | pubmed:meshHeading | pubmed-meshheading:17221172... | lld:pubmed |
| pubmed-article:17221172 | pubmed:meshHeading | pubmed-meshheading:17221172... | lld:pubmed |
| pubmed-article:17221172 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17221172 | pubmed:articleTitle | Presence of D8/17 B-cell marker in patients with poststreptococcal reactive arthritis. | lld:pubmed |
| pubmed-article:17221172 | pubmed:affiliation | Department of Pediatrics C, Schneider Children's Medical Center of Israel, Petach Tikvah, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. liorahar@clalit.org.il | lld:pubmed |
| pubmed-article:17221172 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17221172 | lld:pubmed |
